News
Pharmacy chain BENU is warning that a steep price increase for the blood thinner Eliquis is threatening patient access to ...
Taking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs ...
The companies' new effort would bypass traditional middlemen to cut the drug's monthly cost from a list price of around $606 ...
The joint venture is launching a direct-to-consumer service of Eliquis after discussions with the Trump administration.
The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...
Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and ...
Drugmakers will offer Eliquis at a 43% discount to uninsured U.S. patients, bypassing insurers and PBMs New $346 monthly ...
Apixaban would still cost patients 9 times more through the Eliquis 360 Support program than with commercial insurance.
(Reuters) -Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, ...
Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient ...
Bristol Myers and Pfizer will sell Eliquis directly to U.S. patients at a discounted rate with transparent pricing and ...
BMY gears up for Q2 results as growth drugs partially offset legacy declines, cost cuts kick in and new launches gain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results